PRECIGEN INC

For the period ended Jun 30, 2024. Filed Aug 14, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 14, 2024

PGEN$4.52-4.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets as of and

Condensed Consolidated Balance Sheets

(Amounts in thousands, except share data)	June 30,2024	December 31,2023
Assets
Current assets
Cash and cash equivalents	$9,345	$7,578
Short-term investments	10,191	55,277
Receivables
Trade, less allowance for credit losses of $0 and $184 as of June 30, 2024 and December 31, 2023	511	902
Other	505	673
Prepaid expenses	3,163	4,325
Total current assets	23,715	68,755
Property, plant and equipment, net	13,451	7,111
Intangible assets, net	5,091	40,701
Goodwill	24,918	26,612
Right-of-use assets	5,550	7,097
Other assets	435	767
Total assets	$73,160	$151,043

Condensed Consolidated Balance Sheets

(Amounts in thousands, except share data)	June 30,2024	December 31,2023
Liabilities and Shareholders' Equity
Current liabilities
Accounts payable	$4,846	$1,726
Accrued compensation and benefits	6,675	8,250
Other accrued liabilities	6,642	6,223
Settlement and indemnification accruals	3,213	5,075
Deferred revenue	378	509
Current portion of lease liabilities	1,269	1,202
Total current liabilities	23,023	22,985
Deferred revenue, net of current portion	1,818	1,818
Lease liabilities, net of current portion	5,072	5,895
Deferred tax liabilities	77	1,847
Total liabilities	29,990	32,545
Commitments and contingencies (Note 13)
Shareholders' equity
Common stock, no par value, 400,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 256,398,527 shares issued as of June 30, 2024 and December 31, 2023, 252,656,151 shares and 248,919,096 shares outstanding as of June 30, 2024 and December 31, 2023, respectively.	—	—
Additional paid-in capital	2,093,080	2,084,916
Accumulated deficit	(2,047,001)	(1,964,471)
Accumulated other comprehensive loss	(2,909)	(1,947)
Total shareholders' equity	43,170	118,498
Total liabilities and shareholders' equity	$73,160	$151,043

Condensed Consolidated Statements of Operations

(Amounts in thousands, except share and per share data) · Three Months Ended June 30, · Six Months Ended June 30,
2024 · 2023 · 2024 · 2023
Revenues
Product revenues	$31	$324	$169	$648
Service revenues	673	1,438	1,592	2,965
Other revenues	13	5	21	5
Total revenues	717	1,767	1,782	3,618
Operating Expenses
Cost of products and services	1,014	1,697	2,089	3,224
Research and development	15,693	11,874	29,942	24,037
Selling, general and administrative	10,306	9,316	20,457	20,954
Impairment of goodwill	1,630	—	1,630	—
Impairment of other noncurrent assets	32,915	—	32,915	—
Total operating expenses	61,558	22,887	87,033	48,215
Operating loss	(60,841)	(21,120)	(85,251)	(44,597)
Other Income (Expense), Net
Interest expense	(2)	(136)	(4)	(460)
Interest income	319	828	927	1,460
Other income, net	43	44	80	424
Total other income, net	360	736	1,003	1,424
Loss before income taxes	(60,481)	(20,384)	(84,248)	(43,173)
Income tax benefit	1,689	65	1,718	120
Net loss	$(58,792)	$(20,319)	$(82,530)	$(43,053)
Net loss per share
Net loss per share, basic and diluted	$(0.23)	$(0.08)	$(0.33)	$(0.18)
Weighted average shares outstanding, basic and diluted	252,366,533	248,003,322	250,803,790	240,307,403

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.